Provided by Tiger Trade Technology Pte. Ltd.

AbbVie

259.74
-3.1600-1.20%
Volume:831.51K
Turnover:215.03M
Market Cap:459.06B
PE:73.38
High:262.50
Open:262.50
Low:257.25
Close:262.90
52wk High:267.47
52wk Low:190.75
Shares:1.77B
Float Shares:1.76B
Volume Ratio:0.68
T/O Rate:0.05%
Dividend:6.83
Dividend Rate:2.63%
EPS(TTM):3.54
EPS(LYR):2.36
ROE:6225.00%
ROA:10.51%
PB:-77.35
PE(LYR):110.06

Loading ...

China's WuXi AppTec H1 Revenue Rises, Raises 2026 Guidance

Reuters
·
Aug 03

U.S. Research Roundup-Abbvie, Amazon, Illumina

Reuters
·
Aug 03

JPMorgan Adjusts Price Target on AbbVie to $285 From $280

MT Newswires Live
·
Aug 01

Abbvie Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 01

Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), AbbVie (ABBV) and Cencora (COR)

TIPRANKS
·
Aug 01

AbbVie Earnings Beat Forecasts as Skyrizi Sales Soar 24%. Why the Stock is Falling.

Dow Jones
·
Aug 01

Sector Update: Healthcare

MT Newswires Live
·
Aug 01

AbbVie Targets Ovarian Cancer Biomarkers With New FRa Concordance Study

TIPRANKS
·
Aug 01

AbbVie’s New AML Combo Trial Aims to Boost Its Oncology Pipeline

TIPRANKS
·
Aug 01

AbbVie Publishes Pipeline Presentation Highlighting July 2026 R&D Program Updates

Reuters
·
Jul 31

AbbVie Stock Falls as Guidance Cut Overshadows Strong Q2 Earnings Beat

Benzinga Earnings
·
Jul 31

Movement Alert|AbbVie Falls 3.04% in Regular Trading, Q2 Beat Overshadowed by Full-Year EPS Guidance Cut on Acquisition Dilution

Market Focus
·
Jul 31

AbbVie says ‘quite pleased’ with Skyrizi momentum

TIPRANKS
·
Jul 31

AbbVie Has 2Q Beat Helped by Skyrizi and Rinvoq

Dow Jones
·
Jul 31

Abbvie Shares Down 2.2% After Co Trims 2026 Profit Forecast

THOMSON REUTERS
·
Jul 31

Abbvie Exec Says NOW Expect Total Annual Net Revenue of Approximately $67.6 Billion, Increase of $300 Million Versus Previous Forecast - Conf Call

THOMSON REUTERS
·
Jul 31

Abbvie Exec Says in Third Quarter it Expects Adjusted Profit Per Share Between $3.84 and $3.88 - Conf Call

THOMSON REUTERS
·
Jul 31

AbbVie Bought Apogee to Strengthen Its Portfolio. Now It's Cutting Earnings Guidance.

Dow Jones
·
Jul 31

AbbVie Lowers Outlook to Account for Acquisition, as 2Q Profit Jumps

Dow Jones
·
Jul 31

AbbVie Q2 Adjusted Earnings, Revenue Rise

MT Newswires Live
·
Jul 31